LIGAND PHARMACEUTICALS INC (LGNZZ)

Pharmaceutical Preparations · Healthcare · $2.5B

overvalued
Intrinsic Value (Consensus)
$70.28
Current Price
$122.60
Margin of Safety
-42.7%
42.7% Above Intrinsic Value
Value: $70
Price: $123

Valuation Model Estimates

Current Price: $122.60
DCF (Discounted Cash Flow)
$38.42
Graham Number
$83.69
Earnings Power Value
$59.51
Relative Value (P/E)
$122.60
Dividend Discount Model
$47.17
Consensus Value
$70.28

Model Assumptions

Discount Rate
10.3%
Growth Rate
5.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%

Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.

Key Financials

EPS (TTM)
$6.13
EPS (Forward)
$6.44
Book Value
$50.79
P/E Ratio
20.0
Forward P/E
19.0
PEG Ratio
ROE
12.2%
Debt/Equity
3%
Revenue Growth
60.4%
Earnings Growth
5.0%
Dividend Yield
2.0%
Beta
1.00

Data last updated: 2026-06-12

Source: Yahoo Finance